Clinical Trials Directory

Trials / Terminated

TerminatedNCT03898817

Pathology of Helicases and Premature Aging: Study by Derivation of hiPS

Status
Terminated
Phase
Study type
Observational
Enrollment
3 (actual)
Sponsor
University Hospital, Montpellier · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Topic of this work is the involvement of replicative helicases in human premature ageing syndrome. Replicative helicases are ubiquitous and essential during numerous reactions of the DNA metabolism. The family of replicative helicases (RecQL) is involved in the replication/repair of the DNA and in the telomere maintenance. There are 5 enzymes in human and 3 of them are involved in clinically recognizable syndromes: WRN for the Werner syndrome, BLM for the Bloom syndrome and RECQL4 for the Rothmund Thomson syndrome. All are responsive of a high cancer risk due to genomic instability. Molecular and cellular mechanisms involved in these diseases of ageing are unknown. Moreover, for all of them, there is not therapeutic or preventive solution.

Detailed description

For understanding the involved mechanisms we would like to model the 3 diseases with hiPS (human induced Pluripotent Stem cells) from somatic cells of patients. The patient recruitment was organized by the Montpellier and Nîmes public hospitals. The project is to generate a hiPS cell line for the 3 syndromes from fibroblasts and/or blood samples. Then, we could induce differentiation of hiPS to a target cell line of the diseases. Finally we could study the disease development following the genomic instability (karyotype, array-CGH) and the cellular ageing (senescence-associated heterochromatin foci, telomere length). For each mutated enzyme, we will perform a transcriptional profiling (splice, mRNA quantification) and protein studies (western blot). All results will be compared to wild type cells.

Conditions

Interventions

TypeNameDescription
OTHERtaking of cutaneous cellsTaking of cutaneous cells by biopsy Sample of blood

Timeline

Start date
2015-09-09
Primary completion
2017-09-09
Completion
2017-09-09
First posted
2019-04-02
Last updated
2021-12-29

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03898817. Inclusion in this directory is not an endorsement.